These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 6499208

  • 21. Prolidase and prolidase deficiency.
    Myara I, Charpentier C, Lemonnier A.
    Life Sci; 1984 May 21; 34(21):1985-98. PubMed ID: 6727550
    [Abstract] [Full Text] [Related]

  • 22. Inhibition of prolidase activity by non-steroid antiinflammatory drugs in cultured human skin fibroblasts.
    Miltyk W, Karna E, Pałka J.
    Pol J Pharmacol; 1996 May 21; 48(6):609-13. PubMed ID: 9112701
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Prolidase deficiency.
    Pedersen PS, Christensen E, Brandt NJ.
    Acta Paediatr Scand; 1983 Sep 21; 72(5):785-8. PubMed ID: 6637477
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Prolidase deficiency in cultured human fibroblasts: biochemical pathology and iminodipeptide-enhanced growth.
    Dolenga M, Hechtman P.
    Pediatr Res; 1992 Oct 21; 32(4):479-82. PubMed ID: 1437403
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Characterization of prolidase I and II purified from normal human erythrocytes: comparison with prolidase in erythrocytes from a patient with prolidase deficiency.
    Uramatsu S, Liu G, Yang Q, Uramatsu M, Chi H, Lu J, Yamashita K, Kodama H.
    Amino Acids; 2009 Sep 21; 37(3):543-51. PubMed ID: 19263194
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Intracellular delivery of liposome-encapsulated prolidase in cultured fibroblasts from prolidase-deficient patients.
    Perugini P, Hassan K, Genta I, Modena T, Pavanetto F, Cetta G, Zanone C, Iadarola P, Asti A, Conti B.
    J Control Release; 2005 Jan 20; 102(1):181-90. PubMed ID: 15653144
    [Abstract] [Full Text] [Related]

  • 33. Human recombinant prolidase from eukaryotic and prokaryotic sources. Expression, purification, characterization and long-term stability studies.
    Lupi A, Della Torre S, Campari E, Tenni R, Cetta G, Rossi A, Forlino A.
    FEBS J; 2006 Dec 20; 273(23):5466-78. PubMed ID: 17081196
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Characteristics and partial purification of prolidase and prolinase from leukocytes of a normal human and a patient with prolidase deficiency.
    Kodama H, Ohhashi T, Ohba C, Ohno T, Arata J, Kubonishi I, Miyoshi I.
    Clin Chim Acta; 1989 Mar 15; 180(1):65-72. PubMed ID: 2743570
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Iminopeptiduria, skin ulcerations, and edema in a boy with prolidase deficiency.
    Sheffield LJ, Schlesinger P, Faull K, Halpern BJ, Schier GM, Cotton RG, Hammond J, Danks DM.
    J Pediatr; 1977 Oct 15; 91(4):578-83. PubMed ID: 908977
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.